News Coverage on GlaxoSmithKline PLC - CTNow
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 56-66
  • UK switches to Merck's Gardasil for HPV vaccination

    UK switches to Merck's Gardasil for HPV vaccination
    LONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil. The move underscores Gardasil's lead in a $1 billion-plus worldwide...
  • Mailbag: Should they sell seashells at store?

    Perhaps instead of fighting over how many merchants in town sell seashells, they should consider not selling them at all ("Fighting over some seashells," Dave Hansen column, June 2). Yes, I know, they are big sellers, and make money for the merchants....
  • Antidepressants and pregnancy

    Antidepressants and pregnancy
    Upon learning they are pregnant, most women dutifully nix the alcohol, sushi and caffeine. But what about antidepressants? Headlines about the potential risks of antidepressants on a developing fetus, including miscarriage, premature birth and newborn...
  • Group backs HPV shot recommendation for boys

    Group backs HPV shot recommendation for boys
    NEW YORK (Reuters Health) - Boys 11 years and up should get Merck & Co's Gardasil vaccine to protect them against HPV infections, which can cause genital warts as well as oral, penile and anal cancers, the nation's largest group of pediatricians said...
  • Tailored breast cancer drugs in focus at cancer meet

    Tailored breast cancer drugs in focus at cancer meet
    ZURICH (Reuters) - Doctors and investors at a cancer conference starting on Friday will be keen to find out more on the effectiveness of two promising new breast cancer drugs from Swiss drugmakers Roche and Novartis. Roche's T-DM1 and Novartis's Afinitor...
  • Cancer study boosts hopes for Roche's armed antibody

    Cancer study boosts hopes for Roche's armed antibody
    STOCKHOLM (Reuters) - Women with an aggressive type of advanced breast cancer can live significantly longer without their disease getting worse if they are treated with an experimental "armed antibody" drug from Roche, researchers said on Sunday. Data...
  • Drug companies pay $25 million to Illinois doctors

    Drug companies pay $25 million to Illinois doctors
    At least three dozen doctors in Illinois received payments and perks exceeding $100,000 from drug companies between 2009 and early 2011, according to an updated database that now includes information from a dozen pharmaceutical firms. Doctors in the...
  • Asthma drugs may increase attacks in kids: report

    Asthma drugs may increase attacks in kids: report
    NEW YORK (Reuters Health) - One class of drugs used to prevent wheezing and shortness of breath in people with asthma may increase kids' risk of being hospitalized for an asthma attack, according to a new analysis from the U.S. Food and Drug...
  • IUDs almost halve risk of cervical cancer: study

    IUDs almost halve risk of cervical cancer: study
    LONDON (Reuters) - Contrary to popular belief, intrauterine contraceptive devices might actually protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease, according to the results of...
  • Dangerous pharmaceuticals marketed as supplements

    Dangerous pharmaceuticals marketed as supplements
    Shengyang Zhou assured the American buyers that his Chinese-made weight-loss capsules were safe. Zhou was sure because he had a test — one person eats a whole bottle. Such a person would have "maybe some stomach problem, but not die," he told...
  • EU advises all girls need cervical cancer vaccines

    EU advises all girls need cervical cancer vaccines
    LONDON (Reuters) - All girls in Europe should be immunized against the human papillomavirus (HPV) that causes cervical cancer and current vaccine coverage rates are far too low, European Union health officials said on Wednesday. In new advice about...